{
    "clinical_study": {
        "@rank": "67338", 
        "brief_summary": {
            "textblock": "This study is used by the Digestive Diseases Branch to evaluate patients with suspected\n      abnormalities in the secretion of gastric acid.  The level of gastric acid is measured by\n      analyzing the gastric juices of each individual patient.  The gastric acid sample is\n      obtained by a procedure known as nasogastric suctioning, where a thin plastic tube is passed\n      from the nose to the stomach.\n\n      Depending on the patient's present condition further diagnostic testing may be required to\n      achieve a diagnosis."
        }, 
        "brief_title": "Evaluating Patients With Abnormal Levels of Gastric Acid", 
        "completion_date": "January 2004", 
        "condition": [
            "Achlorhydria", 
            "Gastrinoma", 
            "Zollinger Ellison Syndrome"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Achlorhydria", 
                "Gastrinoma", 
                "Zollinger-Ellison Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study is an omnibus protocol used by the Digestive Diseases Branch to evaluate patients\n      with suspected abnormalities of gastric acid secretion.  Gastric acid secretion is measured\n      by means of analysis of gastric juices obtained by nasogastric suction.  Other clinically\n      indicated diagnostic procedures are performed depending on the patient's clinical state in\n      order to reach a diagnosis."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Eligibility criteria not identified in the protocol."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "firstreceived_date": "November 3, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001240", 
            "org_study_id": "890005", 
            "secondary_id": "89-DK-0005"
        }, 
        "keyword": [
            "Stomach", 
            "Hypersecretion", 
            "Hyposecretion", 
            "Gastrinoma", 
            "Zollinger-Ellison Syndrome"
        ], 
        "lastchanged_date": "March 4, 2008", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Diagnostic Evaluation of Patients With Suspected Abnormalities of Gastric Secretion", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "3972233", 
                "citation": "McArthur KE, Collen MJ, Maton PN, Cherner JA, Howard JM, Ciarleglio CA, Cornelius MJ, Jensen RT, Gardner JD. Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome. Gastroenterology. 1985 Apr;88(4):939-44."
            }, 
            {
                "PMID": "2857672", 
                "citation": "Howard JM, Chremos AN, Collen MJ, McArthur KE, Cherner JA, Maton PN, Ciarleglio CA, Cornelius MJ, Gardner JD, Jensen RT. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. Gastroenterology. 1985 Apr;88(4):1026-33."
            }, 
            {
                "PMID": "2877575", 
                "citation": "Vinayek R, Howard JM, Maton PN, Wank SA, Slaff JI, Gardner JD, Jensen RT. Famotidine in the therapy of gastric hypersecretory states. Am J Med. 1986 Oct 24;81(4B):49-59."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001240"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "January 1989", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "January 2004"
    }, 
    "geocoordinates": {
        "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)": "38.985 -77.095"
    }
}